These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10742583)

  • 21. Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells.
    Jilek S; Ulrich M; Merkle HP; Walter E
    Pharm Res; 2004 Jul; 21(7):1240-7. PubMed ID: 15290866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
    Hu Y; Hollinger JO; Marra KG
    J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.
    Walter E; Moelling K; Pavlovic J; Merkle HP
    J Control Release; 1999 Sep; 61(3):361-74. PubMed ID: 10477808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE; Nam YS; Lee KH; Park TG
    J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
    Carrasquillo KG; Ricker JA; Rigas IK; Miller JW; Gragoudas ES; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):290-9. PubMed ID: 12506087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of PLGA microparticles by an emulsion-extraction process using glycofurol as polymer solvent.
    Aubert-Pouëssel A; Venier-Julienne MC; Saulnier P; Sergent M; Benoît JP
    Pharm Res; 2004 Dec; 21(12):2384-91. PubMed ID: 15648273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of DNA encapsulation into PLGA microparticles using modified double emulsion methods and spray drying techniques.
    Oster CG; Kissel T
    J Microencapsul; 2005 May; 22(3):235-44. PubMed ID: 16019909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.
    Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP
    J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery: in vitro evaluation in human prostate cancer cells.
    Moffatt S; Cristiano RJ
    Int J Pharm; 2006 Jul; 317(1):10-3. PubMed ID: 16713147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of encapsulation of suicide gene in poly(D,L-lactic-co-glycolic acid) nanoparticles and its characteristics in vitro].
    He Q; Zhang Z; Liu J; Shu M; Zhang H; Lu Y; Nie F; Luo P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jan; 19(1):30-3. PubMed ID: 11951516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein release microparticles based on the blend of poly(D,L-lactic-co-glycolic acid) and oligo-ethylene glycol grafted poly(L-lactide).
    Cho KY; Choi SH; Kim CH; Nam YS; Park TG; Park JK
    J Control Release; 2001 Oct; 76(3):275-84. PubMed ID: 11578742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encapsulation of protamine sulphate compacted DNA in polylactide and polylactide-co-glycolide microparticles.
    Dunne M; Bibby DC; Jones JC; Cudmore S
    J Control Release; 2003 Sep; 92(1-2):209-19. PubMed ID: 14499198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process.
    Cho M; Sah H
    J Microencapsul; 2005 Feb; 22(1):1-12. PubMed ID: 16019886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheres.
    Varde NK; Pack DW
    J Control Release; 2007 Dec; 124(3):172-80. PubMed ID: 17928089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and statistical optimization of novel double-incorporated PLA-PLGA microparticles within an alginate-pectinate platform for the delivery of nicotine.
    Singh N; Seedat F; Pillay V; Sweet JL; Danckwerts MP
    J Microencapsul; 2006 Mar; 23(2):153-67. PubMed ID: 16754372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
    Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods.
    Atuah KN; Walter E; Merkle HP; Alpar HO
    J Microencapsul; 2003; 20(3):387-99. PubMed ID: 12881118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticles.
    Tse MT; Blatchford C; Oya Alpar H
    Int J Pharm; 2009 Mar; 370(1-2):33-40. PubMed ID: 19059325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.